Photon radiotherapy
Sponsors
Umeå University, Danish Head and Neck Cancer Group, University of Aarhus, Centre Francois Baclesse, Chang Gung Memorial Hospital
Conditions
Anal Cancer Squamous CellBreast CancerCavernous Sinus MeningiomaCognitive ImpairmentDiffuse GliomaDurvalumabEsophageal CancerHCC - Hepatocellular Carcinoma
Phase 2
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
RecruitingNCT06339424
Start: 2024-03-30End: 2031-03-30Target: 45Updated: 2025-05-14
A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.
RecruitingNCT06677879
Start: 2024-08-01End: 2028-07-31Target: 780Updated: 2025-05-30
Photon Radiotherapy Plus Tremelimumab/Durvalumab for BCLC Stage B and C HCC
RecruitingNCT06999707
Start: 2025-05-22End: 2033-05-31Target: 45Updated: 2025-06-05
Phase 3
Unknown Phase
Proton Versus Photon Therapy in Anal Squamous Cell Carcinoma
RecruitingNCT04462042
Start: 2021-04-07End: 2031-03-28Target: 100Updated: 2025-04-03
DAHANCA 35: Proton Versus Photon Therapy for Head-neck Cancer
NCT04607694
Start: 2020-10-09End: 2025-09-30Target: 600Updated: 2020-10-29
Long-term Cognitive and Functional Impact of Proton-therapy or Modern Fractionated Radiotherapy in Cavernous Sinus Meningioma: An Open-label Randomized 1:1 Phase III Study
RecruitingNCT05895344
Start: 2024-02-26End: 2032-08-31Target: 160Updated: 2025-09-29
Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors
RecruitingNCT06831461
Start: 2025-07-01End: 2032-12-31Target: 156Updated: 2025-09-16